IGWM
DMRA

ICA Group Wealth Management’s Damora Therapeutics DMRA Stock Holding History

ICA Group Wealth Management’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30
Closed -$585 – 984
2024
Q1 		$585 Buy
+30
New +$533 ﹤0.01% 1285

Other funds holding DMRA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

ICA Group Wealth Management's DMRA Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Damora Therapeutics (DMRA) in Q2 2024, closing a stake of 30 shares — an estimated $585 sold.

ICA Group Wealth Management first reported a position in DMRA in Q1 2024 and held it in 1 quarter. The position peaked at $585 in Q1 2024. 22 funds tracked by Wall St. Rank hold DMRA as of Q2 2024.

  • ICA Group Wealth Management reported no remaining Damora Therapeutics position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 30 Damora Therapeutics shares in Q2 2024, an estimated $585.
  • ICA Group Wealth Management first reported a position in Damora Therapeutics in Q1 2024 and held it in 1 quarter.
  • ICA Group Wealth Management's Damora Therapeutics position peaked at $585 in Q1 2024.
  • 22 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.